MedTrace Logo

Zinc Therapy in HIV Infected Individuals Who Abuse Drugs

NCT00149552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231

Last updated 2012-03-05

No results posted yet for this study

Summary

Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.

Conditions

  • HIV Infections
  • Substance-Related Disorders

Interventions

DIETARY_SUPPLEMENT

zinc

supplementation with zinc gluconate

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Florida International University

    lead OTHER

Principal Investigators

  • Marianna K. Baum, PhD · Florida International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149552 on ClinicalTrials.gov